Hemofília: nyitott vizsgálatok itt: Németország
29 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Berlin, Bonn, Frankfurt Am Main, Freiburg im Breisgau, Hamburg, Hanover
- Age
- 12 év and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604EU 2025-522435-33-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
- Where
- Berlin, Bonn, Hanover, Leipzig, Regensburg
- Age
- 18 év and over
- People
- 84 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07830732EU 2026-525529-19-00Regiszter frissítve: 2026-10-28
3. fázisToborozResearch participation
Efanesoctocog alfa treatment in patients with congenital hemophilia A suffering from inflammation of joint lining
- Where
- Berlin, Bonn, Dresden, Duisburg, Frankfurt am Main, Frankfurt Am Main, Giessen, Hamburg, Hanover, Homburg, Kiel, Leipzig, Regensburg
- Age
- 18 év and over
- People
- 60 worldwide
- Run by
- GWT-Tud GmbH
See details and how to join2025-523896-44-00EU 2025-523896-44-00Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- Where
- Munich
- Age
- 1 év to 11 év
- People
- 85 worldwide
- Run by
- Sanofi
See details and how to joinNCT07285460EU 2025-521858-42-00Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Berlin
- Age
- 1 év to 74 év
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127EU 2022-500470-33-00Regiszter frissítve: 2026-10-26
3. fázisToborozTrial-stage medicine
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Berlin, Bonn, Frankfurt Am Main, Freiburg im Breisgau, Hanover
- Age
- 12 év and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526EU 2025-522434-32-00Regiszter frissítve: 2026-10-26
3. fázisToborozResearch participation
A Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
- Where
- Berlin, Bonn
- Age
- 18 év to 64 év
- People
- 32 worldwide
- Run by
- Pfizer Inc.
See details and how to join2025-523660-21-00EU 2025-523660-21-00Regiszter frissítve: 2026-10-23
1/2. fázisToborozTrial-stage medicine
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- Where
- Bonn, Frankfurt Am Main, Hamburg
- Age
- 2 év and over
- People
- 130 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06379789EU 2023-507260-40-00Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Berlin
- Age
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801EU 2022-500495-65-00Regiszter frissítve: 2026-10-14
3. fázisToborozResearch participation
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Where
- Bonn
- Age
- 18 év and over
- People
- 173 worldwide
- Run by
- Pfizer
See details and how to joinNCT05568719Regiszter frissítve: 2026-10-07
No phaseCsak meghívásosResearch participation
Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany
- Where
- Mainz
- Age
- 18 év and over
- People
- 150
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07653139Regiszter frissítve: 2026-10-06
4. fázisToborozResearch participation
Treatment of Hemophilia A Patients With FVIII Inhibitors
- Where
- Bonn, Duisburg, Frankfurt am Main, Giessen, Muenster
- People
- 120 worldwide
- Run by
- Emory University
See details and how to joinNCT04023019EU 2024-516741-39-00Regiszter frissítve: 2026-09-23
1. fázisToborozTrial-stage medicine
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Where
- Berlin, Bonn, Hanover
- Age
- 18 év to 64 év
- People
- 30 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07220564EU 2025-520490-38-00Regiszter frissítve: 2026-09-18
4. fázisToborozResearch participation
Nuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
- Where
- Bonn, Hamburg
- People
- 17 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502061-17-00EU 2022-502061-17-00Regiszter frissítve: 2026-07-10
No phaseCsak meghívásosResearch participation
A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
- Where
- Berlin, Bonn
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT03745924Regiszter frissítve: 2026-06-12
No phaseToborozResearch participation
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Berlin, Bonn, Duisburg, Essen, Frankfurt
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978Regiszter frissítve: 2026-06-02
4. fázisToborozTrial-stage medicine
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
- Where
- Berlin, Duisburg, Hamburg
- Age
- 12 év and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05935358Regiszter frissítve: 2026-05-12
4. fázisToborozTrial-stage medicine
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
- Where
- Bonn, Duisburg, Hamburg
- Age
- 12 év and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05936580Regiszter frissítve: 2026-05-12
No phaseToborozResearch participation
A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI
- Where
- Frankfurt am Main
- People
- 300
- Run by
- Haemophilia Centre Rhine Main
See details and how to joinNCT02207894Regiszter frissítve: 2026-04-21
No phaseToborozResearch participation
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- Where
- Berlin, Bonn, Frankfurt, Hanover
- Age
- 18 év and over
- People
- 500 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06008938Regiszter frissítve: 2026-02-19
4. fázisCsak meghívásosResearch participation
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Berlin, Bonn
- Age
- 18 év and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386EU 2023-507749-27-00Regiszter frissítve: 2026-01-12
No phaseCsak meghívásosResearch participation
A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
- Where
- Berlin, Bonn
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT04574076Regiszter frissítve: 2025-12-22
No phaseCsak meghívásosResearch participation
Feasibility and Safety of Blood-Flow-Restriction Training in Patients With Hemophilia
- Where
- Bonn
- Age
- 18 év and over
- People
- 12
- Run by
- University Hospital, Bonn
See details and how to joinNCT07259356Regiszter frissítve: 2025-12-02
4. fázisToborozResearch participation
Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
- Where
- Berlin, Hamburg
- People
- 45 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502060-21-00EU 2022-502060-21-00Regiszter frissítve: 2025-09-25
No phaseToborozResearch participation
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
- Where
- Berlin, Bonn, Bremen, Frankfurt, Frankfurt am Main, Munich
- People
- 4000 worldwide
- Run by
- PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119Regiszter frissítve: 2025-09-16
Minden vizsgálat (Hemofília) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.